(Q57088778)

4

0 references

author name string

A. Bhangu

1

0 references

G. Wood

2

0 references

P. Tekkis

5

0 references

R. Goldin

Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.

6

0 references

publication date

14 March 2014

0 references

published in

Colorectal Disease

0 references

volume

16

0 references

issue

4

0 references

page(s)

O133-O143

0 references

cites work

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

Epithelial mesenchymal transition in colorectal cancer: Seminal role in promoting disease progression and resistance to neoadjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

The basics of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

Overcoming drug resistance in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

Stem cells: their role in breast cancer development and resistance to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

Revised TN categorization for colon cancer based on national survival outcomes data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

E-cadherin-catenin cell-cell adhesion complex and human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

Pancreatic Cancer Cells Resistant to Chemoradiotherapy Rich in “Stem-Cell-Like” Tumor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

In vitro and in vivo inhibitory effect of three Cox-2 inhibitors and epithelial-to-mesenchymal transition in human bladder cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482

A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCODI.12482